In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

India is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...

Bio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

Social Security COLA 2026 Inflation Gap: Why 2.8% Increase Trails 3.3% Senior Inflation. The 2.8% Social Security COLA for 2026 is failing....

Airbus landing on highway: The exercise was organised to assess the expressway’s potential as an alternative runway during times of war or ...

In 2012, a parliamentary standing committee of the health ministry had observed in its report that some of the state licensing authorities ...

In a letter dated December 18, the drug regulator said that FDC (fixed-dose combination) chlorpheniramine maleate and phenylephrine should ...

The matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC...

The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD...

Wockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7...

The ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry

The FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...